Where Research Ethics Came From

Part of Clinical Research Coordinator (CRC) Training: Ethics and Participant Protection.

About 5 minutes. Free, in your language, no account needed.

Why this matters

You will one day be asked to do something that is convenient and wrong. Enroll a person who is nearly eligible. Let a signature be added later. Skip a question because the clinic is running late.

Rules alone will not stop you, because rules can be argued with. Knowing why the rule exists will. Every safeguard in this course was written after somebody was harmed.

The events that shaped the rules

YearEventWhat it established
1947The Nuremberg Code, written after the trials of Nazi doctorsVoluntary consent of the human subject is absolutely essential.
1964The Declaration of Helsinki, adopted by the World Medical AssociationEthical principles for medical research involving human participants.
1966Henry Beecher publishes "Ethics and Clinical Research"Showed that unethical studies were common in ordinary, respected medicine.
1972The Tuskegee syphilis study is publicly exposed and stoppedForced national reform of human subject protection in the United States.
1979The Belmont Report is publishedNamed respect for persons, beneficence, and justice.
2024The Declaration of Helsinki is revised againThe current operative text of the Declaration.

Two of these deserve more than a table row.

Tuskegee. From 1932, United States public health researchers followed hundreds of Black men with syphilis in Alabama in order to observe the untreated course of the disease. The men were not told what they had. When penicillin became a standard cure in the 1940s, it was withheld from them. The study continued until a journalist exposed it in 1972.

Nothing in Tuskegee was secret from the medical profession. It was published. It ran for forty years inside a system that considered itself ethical. That is the part to remember.

Beecher. In 1966, an American anaesthesiologist published a paper describing twenty-two studies, drawn from mainstream journals, in which patients had been placed at risk without meaningful consent. He did not describe villains. He described a normal professional culture that had stopped asking.

The Declaration of Helsinki

The Declaration of Helsinki is the document that clinical research ethics is most directly built on. It was first adopted by the World Medical Association in 1964 and has been revised repeatedly since. The current version is the 2024 revision, titled Ethical Principles for Medical Research Involving Human Participants.

It matters to your daily work for a specific reason. ICH E6(R3), the Good Clinical Practice guideline you will meet in Module 3, does not invent its ethics. Its first principle states that clinical trials should be conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki. Good Clinical Practice is the operating manual. The Declaration is the reason.

One idea from the Declaration is worth carrying into every shift. The wellbeing of the individual participant takes precedence over all other interests, including the interests of science and of society. When a trial requirement and a participant's welfare genuinely conflict, the participant wins. You will not have to make that call often. When you do, it is not a close question.

Why history keeps repeating

The failures above share a shape, and you can recognize the shape today.

Modern safeguards are aimed at that shape. Independent ethics review exists because researchers cannot judge their own studies. Written informed consent exists because a verbal understanding between unequal parties is not reliable. Monitoring and inspection exist because self-reporting is not enough.

In practice

Nadia is screening for VT-201 at Northside Clinic. Enrollment is behind target and Vantis Pharma has sent two reminders.

A man arrives who is interested and, on paper, eligible. During the discussion Nadia notices that he answers every question by looking at his son, who brought him and who does most of the talking. When she asks the father directly what he understands the study to be, he says it is the new medicine the doctor wants him to have.

He is not refusing. He is agreeing to something he has not understood, in front of someone whose approval he wants. Nadia stops. She arranges a second appointment, alone, with an interpreter in his first language.

He enrolls two weeks later, and this time he can describe the study himself, including the fact that he might receive the older tablet.

The enrollment target slipped by two weeks. That is the entire cost, and it was the right price.

Key takeaways